Finally, we analyzed the adaptive immune populations, and observed that tumor-bearing scaffolds had fewer total T cells (CD45+ CD3+), and fewer CD8+ T cells compared with control (Figs S1E and 1E). This evidence concerns the gene PTPRC and neoplasm.